BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24117619)

  • 1. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
    Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
    Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
    Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
    Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
    Molina-Infante J; Katzka DA; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
    Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia.
    Iwakura N; Fujiwara Y; Tanaka F; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Watanabe T; Iijima K; Koike T; Walls AF; Arakawa T
    Aliment Pharmacol Ther; 2015 Apr; 41(8):776-84. PubMed ID: 25693747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia.
    Podboy A; Katzka DA; Enders F; Larson JJ; Geno D; Kryzer L; Alexander J
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1168-77. PubMed ID: 27028344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies.
    Kia L; Hirano I
    Nat Rev Gastroenterol Hepatol; 2015 Jul; 12(7):379-386. PubMed ID: 25986303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
    Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
    Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
    Frandsen LT; Westmark S; Melgaard D; Krarup AL
    United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
    Dohil R; Newbury RO; Aceves S
    Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
    Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.